Alliances
Partnership leverages Bittium’s technology along with Preventice’s expertise in 24/7 remote cardiac monitoring and patient experience
Global contract development and manufacturing organisation Recipharm, has announced that it is joining the AMR Industry Alliance as part of its ambition to contribute to exploring solutions to tackle growing concerns around antimicrobial resistance
Antibiotic resistance continues to grow as a public health threat; local health department efforts critical to addressing issue
Radiologists and care providers around the world will have access to MaxQ AI’s ACCIPIO® ICH and Stroke Platform through Arterys’ cloud-native medical imaging platform.
Cross-industry collaboration will accelerate digital solutions and support R&D innovation by customers
The bioregion is from until November 13 participating at the 25th Annual International Partnering Conference BIO-Europe 2019 in Hamburg.
Heidelberg Pharma AG announced that its partner Magenta Therapeutics, Cambridge, MA, USA, declared that it will exercise the option for the exclusive worldwide development and marketing rights for Antibody Targeted Amanitin Conjugates targeting CD45.
Ubiquigent Limited and LEO Pharma A/S announced that they have entered into an option agreement granting LEO Pharma access to two novel compounds.
Lytix Biopharma AS announces a clinical collaboration with the US-based company Iovance Biotherapeutics, Inc., a late-stage biotechnology company developing novel cancer immunotherapies based on tumor infiltrating lymphocyte technology, to evaluate Lytix`s first-in-class oncolytic peptide, LTX-315, in combination with Iovance`s autologous ready to infuse T cell therapy.
This technology is applicable to both personalized pain treatment and the development of novel pain management therapies, such as non-opioid medications.
PRESS RELEASES